Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
After a CVA, all of the cognitive functions can be affected and analysed, but the presence of a language disorder may considerably hamper the evaluation of other functions.
The battery of rapid tests to screen for and quantify cognitive disorders, including the MMSE, the MOCA, the R-CAMCOG or the RBANS, are not suitable for aphasic patients because they contain items with a strictly verbal response. Because of this, inexperienced doctors cannot evaluate higher functions (other than language) of aphasics in routine practice. For the same reason, aphasics are regularly excluded from post-cva therapeutic protocols, whether or not the trial bears on the evolution of cognitive functions.
Nonetheless, it is possible to evaluate, at least roughly, all of the cognitive functions without resorting to language.
The investigator have developed , from validated tests and classical clinical manoeuvers, the Cognitive Assessment for Stroke Patients (CASP) :
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cognitive Assessment | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cognitive Assessment test | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| comprehensive assessment battery of higher functions | baseline | |
| comprehensive assessment battery of higher functions | Evaluation at 3 ±1 days | |
| comprehensive assessment battery of higher functions | Evaluation at 6 ± 2 weeks | |
| test of visual memory | baseline | |
| test of visual memory | Evaluation at 3 ±1 days | |
| test of visual memory | Evaluation at 6 ± 2 weeks |
Not provided
Not provided
Inclusion Criteria:
For CVA patients
For " Control " patients (to evaluate divergent validity)
Exclusion Criteria:
For CVA patients
For " Control " patients (to evaluate divergent validity)
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Dijon | Dijon | 21079 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34687958 | Result | Benaim C, Wauquiez G, Perennou D, Piscicelli C, Lucas-Pineau B, Bonnin-Koang HY, Vuadens P, Binquet C, Bourredjem A, Devilliers H. Cognitive assessment scale for stroke patients (CASP): A multicentric validation study. Ann Phys Rehabil Med. 2022 May;65(3):101594. doi: 10.1016/j.rehab.2021.101594. Epub 2021 Nov 17. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |